Search Results - "Simpson, Peter T"

Refine Results
  1. 1

    Invasive lobular carcinoma of the breast: the increasing importance of this special subtype by McCart Reed, Amy E, Kalinowski, Lauren, Simpson, Peter T, Lakhani, Sunil R

    Published in Breast cancer research : BCR (07-01-2021)
    “…Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types, accounting for up to 15% of all breast cancer cases. ILCs are noted for…”
    Get full text
    Journal Article
  2. 2

    Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics by McCart Reed, Amy E, Kutasovic, Jamie R, Lakhani, Sunil R, Simpson, Peter T

    Published in Breast cancer research : BCR (30-01-2015)
    “…Invasive lobular carcinoma of the breast is the most common 'special' morphological subtype of breast cancer, comprising up to 15% of all cases. Tumours are…”
    Get full text
    Journal Article
  3. 3

    Metastatic progression of breast cancer: insights from 50 years of autopsies by Cummings, Margaret C, Simpson, Peter T, Reid, Lynne E, Jayanthan, Janani, Skerman, Joanna, Song, Sarah, McCart Reed, Amy E, Kutasovic, Jamie R, Morey, Adrienne L, Marquart, Louise, O'Rourke, Peter, Lakhani, Sunil R

    Published in The Journal of pathology (01-01-2014)
    “…There remain no clear guidelines for the optimal management of patients with metastatic breast cancer. To better understand its natural history, we undertook a…”
    Get full text
    Journal Article
  4. 4

    miR-139-5p is a regulator of metastatic pathways in breast cancer by Krishnan, Keerthana, Steptoe, Anita L, Martin, Hilary C, Pattabiraman, Diwakar R, Nones, Katia, Waddell, Nic, Mariasegaram, Mythily, Simpson, Peter T, Lakhani, Sunil R, Vlassov, Alexander, Grimmond, Sean M, Cloonan, Nicole

    Published in RNA (Cambridge) (01-12-2013)
    “…Metastasis is a complex, multistep process involved in the progression of cancer from a localized primary tissue to distant sites, often characteristic of the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Expression of MAGE‐A and NY‐ESO‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers by Raghavendra, Ashwini, Kalita‐de Croft, Priyakshi, Vargas, Ana C, Smart, Chanel E, Simpson, Peter T, Saunus, Jodi M, Lakhani, Sunil R

    Published in Histopathology (01-07-2018)
    “…Aims A better understanding of the expression of cancer/testis antigens (CTAs) in breast cancer might enable the identification of new immunotherapy options,…”
    Get full text
    Journal Article
  7. 7

    Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content by Ganesamoorthy, Devika, Robertson, Alan James, Chen, Wenhan, Hall, Michael B, Cao, Minh Duc, Ferguson, Kaltin, Lakhani, Sunil R, Nones, Katia, Simpson, Peter T, Coin, Lachlan J M

    Published in BMC cancer (20-01-2022)
    “…Circulating cell-free DNA (cfDNA) in the plasma of cancer patients contains cell-free tumour DNA (ctDNA) derived from tumour cells and it has been widely…”
    Get full text
    Journal Article
  8. 8

    B7-H3 Expression in Breast Cancer and Brain Metastasis by Joshi, Vaibhavi, Beecher, Kate, Lim, Malcolm, Stacey, Andrew, Feng, Yufan, Jat, Parmjit S, Duijf, Pascal H G, Simpson, Peter T, Lakhani, Sunil R, McCart Reed, Amy E

    “…Brain metastasis is a significant challenge for some breast cancer patients, marked by its aggressive nature, limited treatment options, and poor clinical…”
    Get full text
    Journal Article
  9. 9
  10. 10

    MicroRNA-182-5p targets a network of genes involved in DNA repair by Krishnan, Keerthana, Steptoe, Anita L, Martin, Hilary C, Wani, Shivangi, Nones, Katia, Waddell, Nic, Mariasegaram, Mythily, Simpson, Peter T, Lakhani, Sunil R, Gabrielli, Brian, Vlassov, Alexander, Cloonan, Nicole, Grimmond, Sean M

    Published in RNA (Cambridge) (01-02-2013)
    “…MicroRNAs are noncoding regulators of gene expression, which act by repressing protein translation and/or degrading mRNA. Many have been shown to drive…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer by Peters, Amelia A, Simpson, Peter T, Bassett, Johnathon J, Lee, Jane M, Da Silva, Leonard, Reid, Lynne E, Song, Sarah, Parat, Marie-Odile, Lakhani, Sunil R, Kenny, Paraic A, Roberts-Thomson, Sarah J, Monteith, Gregory R

    Published in Molecular cancer therapeutics (01-10-2012)
    “…Calcium signaling is a critical regulator of cell proliferation. Elevated expression of calcium channels and pumps is a characteristic of some cancers,…”
    Get full text
    Journal Article
  13. 13

    Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer by Owens, Thomas W, Rogers, Renee L, Best, Sarah, Ledger, Anita, Mooney, Anne-Marie, Ferguson, Alison, Shore, Paul, Swarbrick, Alexander, Ormandy, Christopher J, Simpson, Peter T, Carroll, Jason S, Visvader, Jane, Naylor, Matthew J

    Published in Cancer research (Chicago, Ill.) (15-09-2014)
    “…Regulators of differentiated cell fate can offer targets for managing cancer development and progression. Here, we identify Runx2 as a new regulator of…”
    Get full text
    Journal Article
  14. 14

    Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast by DA SILVA, Leonard, PARRY, Suzanne, REID, Lynne, KEITH, Patricia, WADDELL, Nic, KOSSAI, Myriam, CLARKE, Catherine, LAKHANI, Sunil R, SIMPSON, Peter T

    Published in The American journal of surgical pathology (01-05-2008)
    “…Invasive lobular carcinoma (ILC) and lobular carcinoma in situ characteristically show loss of E-cadherin expression and so immunohistochemistry for E-cadherin…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer by McCart Reed, Amy E., Song, Sarah, Kutasovic, Jamie R., Reid, Lynne E., Valle, Jordan M., Vargas, Ana Cristina, Smart, Chanel E., Simpson, Peter T.

    “…The thromobospondins are a family of extracellular glycoproteins that are activated during tissue remodeling processes such as embryogenesis, wound healing and…”
    Get full text
    Journal Article